Literature DB >> 17245177

Laparoscopic ischemic conditioning of the stomach for esophageal replacement.

Arnulf H Hölscher1, Paul M Schneider, Christian Gutschow, Wolfgang Schröder.   

Abstract

OBJECTIVES: A considerable percentage of morbidity and mortality after esophagectomy and gastric pull-up is due to leakage of the esophagogastrostomy, which is mainly caused by ischemia of the gastric fundus. Previous clinical studies demonstrated that impaired microcirculation of the gastric conduit almost recovers within the first 5 postoperative days. Therefore, this study was designed to improve gastric perfusion by laparoscopic ischemic conditioning of the stomach.
METHODS: The study group consisted of 83 patients with 44 esophageal adenocarcinomas and 39 squamous cell carcinomas. A total of 51% received neoadjuvant radiochemotherapy. First, all patients underwent laparoscopic mobilization of the stomach including the cardia and preparation of the gastric conduit. After a mean delay of 4.3 days (range, 3-7 days), a conventional right-sided transthoracic en bloc esophagectomy was performed. Reconstruction was done by gastric pull-up and high intrathoracic esophagogastrostomy.
RESULTS: Three conversions (3.6%) to open surgery were necessary during laparoscopic mobilization of the stomach. The reoperation rate was 2.4% (one relaparoscopy for control of a bleeding of the stapler line, one rethoracotomy for chylothorax). Two patients showed circumscribed necroses of the upper part of the fundus after gastric pull-up into the chest. These necroses were resected for reconstruction by esophagogastrostomy. Five patients (6.0%) developed small anastomotic leakages with minor clinical symptoms; however, the gastric conduits were well vascularized. All leakages healed after endoscopic stenting. Major postoperative complications were observed in 13.3% of the patients and the 90-day mortality was 0%.
CONCLUSION: Laparoscopic ischemic conditioning of the gastric conduit is feasible and safe and may contribute to the reduction of postoperative morbidity and mortality after esophagectomy and gastric pull-up.

Entities:  

Mesh:

Year:  2007        PMID: 17245177      PMCID: PMC1876980          DOI: 10.1097/01.sla.0000245847.40779.10

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  45 in total

1.  Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients.

Authors:  Jeffrey Rentz; David Bull; David Harpole; Stephen Bailey; Leigh Neumayer; Theodore Pappas; Barbara Krasnicka; William Henderson; Jennifer Daley; Shukri Khuri
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

2.  Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.

Authors:  Paul M Schneider; Stephan E Baldus; Ralf Metzger; Martin Kocher; Rudolf Bongartz; Elfriede Bollschweiler; Hartmut Schaefer; Juergen Thiele; Hans P Dienes; Rolf P Mueller; Arnulf H Hoelscher
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

3.  The delay phenomenon: the story unfolds.

Authors:  S C Dhar; G I Taylor
Journal:  Plast Reconstr Surg       Date:  1999-12       Impact factor: 4.730

4.  Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy.

Authors:  N T Nguyen; D M Follette; B M Wolfe; P D Schneider; P Roberts; J E Goodnight
Journal:  Arch Surg       Date:  2000-08

5.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

Review 6.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

7.  Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition.

Authors:  John W Briel; Anand P Tamhankar; Jeffrey A Hagen; Steven R DeMeester; Jan Johansson; Emmanouel Choustoulakis; Jeffrey H Peters; Cedric G Bremner; Tom R DeMeester
Journal:  J Am Coll Surg       Date:  2004-04       Impact factor: 6.113

8.  Gastric microcirculatory changes during gastric tube formation: assessment with laser Doppler flowmetry.

Authors:  M K Schilling; C Redaelli; C Maurer; H Friess; M W Büchler
Journal:  J Surg Res       Date:  1996-04       Impact factor: 2.192

9.  Ischemic conditioning of the rat stomach: implications for esophageal replacement with stomach.

Authors:  J D Urschel
Journal:  J Cardiovasc Surg (Torino)       Date:  1995-04       Impact factor: 1.888

10.  Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer.

Authors:  H Bartels; H J Stein; J R Siewert
Journal:  Br J Surg       Date:  1998-06       Impact factor: 6.939

View more
  66 in total

1.  Health-related quality of life after Ivor Lewis esophagectomy.

Authors:  Christian A Gutschow; Arnulf H Hölscher; Jessica Leers; Hans Fuchs; Marc Bludau; Klaus L Prenzel; E Bollschweiler; Wolfgang Schröder
Journal:  Langenbecks Arch Surg       Date:  2012-06-04       Impact factor: 3.445

2.  Esophagogastric anastomosis with invagination into stomach: New technique to reduce fistula formation.

Authors:  Alexandre Cruz Henriques; Carlos Alberto Godinho; Roberto Saad; Daniel Reis Waisberg; Aline Biral Zanon; Manlio Basilio Speranzini; Jaques Waisberg
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

3.  Randomized controlled trial of laparoscopic gastric ischemic conditioning prior to minimally invasive esophagectomy, the LOGIC trial.

Authors:  Darmarajah Veeramootoo; Angela C Shore; Shahjehan A Wajed
Journal:  Surg Endosc       Date:  2012-02-01       Impact factor: 4.584

4.  Hybrid minimally invasive esophagectomy vs. open esophagectomy: a matched case analysis in 120 patients.

Authors:  Torben Glatz; Goran Marjanovic; Birte Kulemann; Olivia Sick; Ulrich Theodor Hopt; Jens Hoeppner
Journal:  Langenbecks Arch Surg       Date:  2017-01-12       Impact factor: 3.445

5.  Comments on the publication "effect of pyloric drainage procedures on gastric passage and bile reflux after esophagectomy with gastric conduit reconstruction by Palmes et al.".

Authors:  Luigi Bonavina
Journal:  Langenbecks Arch Surg       Date:  2007-11-09       Impact factor: 3.445

6.  Esophageal replacement following gastric devascularization is safe, feasible, and may decrease anastomotic complications.

Authors:  Kyle A Perry; C Kristian Enestvedt; Thai H Pham; James P Dolan; John G Hunter
Journal:  J Gastrointest Surg       Date:  2010-05-15       Impact factor: 3.452

7.  Management of Tracheo- or Bronchoesophageal Fistula After Ivor-Lewis Esophagectomy.

Authors:  R Lambertz; A H Hölscher; M Bludau; J M Leers; C Gutschow; W Schröder
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

8.  Esophagectomy without mortality: what can surgeons do?

Authors:  Simon Law
Journal:  J Gastrointest Surg       Date:  2009-09-23       Impact factor: 3.452

9.  Comparison of cervical anastomotic leak and stenosis after oesophagectomy for carcinoma according to the interval of the stomach ischaemic conditioning.

Authors:  V Prochazka; F Marek; L Kunovsky; R Svaton; T Grolich; P Moravcik; M Farkasova; Z Kala
Journal:  Ann R Coll Surg Engl       Date:  2018-06-18       Impact factor: 1.891

10.  Gastric ischemic conditioning increases neovascularization and reduces inflammation and fibrosis during gastroesophageal anastomotic healing.

Authors:  Kyle A Perry; Ambar Banarjee; James Liu; Nilay Shah; Mark R Wendling; W Scott Melvin
Journal:  Surg Endosc       Date:  2012-12-18       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.